Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Κατάταξη σε μετοχές
#2196
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Τιμή μετοχής
$3.40
Κεφαλαιοποίηση
$9.07B
Αλλαγή (1 ημέρα)
-1.61%
Αλλαγή (1 έτος)
-16.08%
Χώρα
CN
Εμπόριο Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Κατηγορία
Healthcare
Κέρδη για την Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Κέρδη τον 2026 TTM: 0
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Shanghai Fosun Pharmaceutical (Group) Co., Ltd., τα τρέχοντα κέρδη της εταιρείας είναι 0. Το 2026, η εταιρεία παρουσίασε κέρδη 0, ίσο με των κερδών του 2026 που ήταν 0. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Shanghai Fosun Pharmaceutical (Group) Co., Ltd. από 2001 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2025 | $730.66M | 27.92% |
| 2024 | $571.20M | 23.86% |
| 2023 | $461.19M | -30.46% |
| 2022 | $663.16M | -30.25% |
| 2021 | $950.72M | 32.77% |
| 2020 | $716.07M | 10.17% |
| 2019 | $649.94M | 24.89% |
| 2018 | $520.40M | -16.64% |
| 2017 | $624.28M | 21.36% |
| 2016 | $514.42M | -0.93% |
| 2015 | $519.24M | 18.33% |
| 2014 | $438.82M | 15.05% |
| 2013 | $381.42M | 12.03% |
| 2012 | $340.46M | 24.30% |
| 2011 | $273.89M | 50.41% |
| 2010 | $182.10M | -61.92% |
| 2009 | $478.18M | 290.45% |
| 2008 | $122.47M | 18.23% |
| 2007 | $103.59M | 135.84% |
| 2006 | $43.92M | 31.65% |
| 2005 | $33.36M | 92.26% |
| 2004 | $17.35M | -58.15% |
| 2003 | $41.46M | 96.02% |
| 2002 | $21.15M | 8.96% |
| 2001 | $19.41M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
